Tekla Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | $23.4M | Sell |
111,183
-6,900
| -6% | -$1.45M | 0.91% | 33 |
|
2023
Q1 | $23.8M | Buy |
118,083
+45,408
| +62% | +$9.16M | 0.91% | 31 |
|
2022
Q4 | $15.8M | Hold |
72,675
| – | – | 0.6% | 41 |
|
2022
Q3 | $14.3M | Buy |
72,675
+24,781
| +52% | +$4.88M | 0.59% | 42 |
|
2022
Q2 | $10.2M | Sell |
47,894
-14,096
| -23% | -$3.02M | 0.4% | 59 |
|
2022
Q1 | $17.6M | Hold |
61,990
| – | – | 0.62% | 44 |
|
2021
Q4 | $23.4M | Sell |
61,990
-16,494
| -21% | -$6.21M | 0.75% | 36 |
|
2021
Q3 | $32.4M | Buy |
78,484
+23,810
| +44% | +$9.83M | 1.04% | 30 |
|
2021
Q2 | $20.2M | Buy |
54,674
+11,600
| +27% | +$4.29M | 0.66% | 41 |
|
2021
Q1 | $12.5M | Buy |
43,074
+14,920
| +53% | +$4.32M | 0.43% | 61 |
|
2020
Q4 | $7.04M | Sell |
28,154
-2,600
| -8% | -$650K | 0.25% | 102 |
|
2020
Q3 | $6.96M | Buy |
30,754
+12,287
| +67% | +$2.78M | 0.26% | 87 |
|
2020
Q2 | $3.22M | Hold |
18,467
| – | – | 0.12% | 134 |
|
2020
Q1 | $2.33M | Sell |
18,467
-2,500
| -12% | -$316K | 0.11% | 127 |
|
2019
Q4 | $3.2M | Sell |
20,967
-4,100
| -16% | -$626K | 0.12% | 135 |
|
2019
Q3 | $3.32M | Buy |
25,067
+10,900
| +77% | +$1.44M | 0.14% | 109 |
|
2019
Q2 | $2.01M | Buy |
14,167
+3,527
| +33% | +$500K | 0.08% | 133 |
|
2019
Q1 | $1.55M | Sell |
10,640
-12,030
| -53% | -$1.75M | 0.06% | 140 |
|
2018
Q4 | $2.57M | Hold |
22,670
| – | – | 0.11% | 116 |
|
2018
Q3 | $3.05M | Hold |
22,670
| – | – | 0.11% | 122 |
|
2018
Q2 | $2.55M | Hold |
22,670
| – | – | 0.1% | 127 |
|
2018
Q1 | $2.42M | Sell |
22,670
-63,134
| -74% | -$6.74M | 0.09% | 127 |
|
2017
Q4 | $9.39M | Sell |
85,804
-41,296
| -32% | -$4.52M | 0.36% | 56 |
|
2017
Q3 | $13.7M | Hold |
127,100
| – | – | 0.49% | 40 |
|
2017
Q2 | $12.9M | Hold |
127,100
| – | – | 0.48% | 49 |
|
2017
Q1 | $11.4M | Sell |
127,100
-500
| -0.4% | -$45K | 0.44% | 50 |
|
2016
Q4 | $9.72M | Buy |
127,600
+12,600
| +11% | +$960K | 0.41% | 58 |
|
2016
Q3 | $9.58M | Buy |
+115,000
| New | +$9.58M | 0.37% | 63 |
|